Status:
RECRUITING
Renal Manifestations During Idiopathic Inflammatory Myopathies
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Inflammatory Myopathy
Eligibility:
All Genders
18+ years
Brief Summary
There are currently no recommendations regarding treatments for Idiopathic Inflammatory Myopathies (IIM) due to the difficulty in conducting high-powered randomized controlled trials. Generally speak...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Major subject (≥ 18 years old)
- Inflammatory myopathy defined by the ACR/EULAR 2017 criteria
- Kidney biopsy performed
- Supported at the Strasbourg University Hospital during the period from January 1, 1990 to May 1, 2023.
- Subject who has not expressed opposition to the reuse of their data for scientific research purposes.
- It is the responsibility of the investigator to verify the absence of opposition in the patient's medical file.
- Exclusion criteria:
- Subject having expressed opposition to participating in the study
- Known etiology of renal damage excluding inflammatory myopathy.
Exclusion
Key Trial Info
Start Date :
January 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 5 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06904937
Start Date
January 5 2024
End Date
December 5 2025
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Rhumatologie - CHU de Strasbourg - France
Strasbourg, France, 67091